UK publicly funded Clinical Trials Units supported a controlled access approach to share individual participant data but highlighted concerns

Objectives Evaluate current data sharing activities of UK publicly funded Clinical Trial Units (CTUs) and identify good practices and barriers. Study Design and Setting Web-based survey of Directors of 45 UK Clinical Research Collaboration (UKCRC)–registered CTUs. Results Twenty-three (51%) CTUs responded: Five (22%) of these had an established data sharing policy and eight (35%) specifically requested consent to use patient data beyond the scope of the original trial. Fifteen (65%) CTUs had received requests for data, and seven (30%) had made external requests for data in the previous 12 months. CTUs supported the need for increased data sharing activities although concerns were raised about patient identification, misuse of data, and financial burden. Custodianship of clinical trial data and requirements for a CTU to align its policy to their parent institutes were also raised. No CTUs supported the use of an open access model for data sharing. Conclusion There is support within the publicly funded UKCRC-registered CTUs for data sharing, but many perceived barriers remain. CTUs are currently using a variety of approaches and procedures for sharing data. This survey has informed further work, including development of guidance for publicly funded CTUs, to promote good practice and facilitate data sharing.

[1]  N. Welton,et al.  Addressing between‐study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non‐rheumatic atrial fibrillation , 2009, Statistics in medicine.

[2]  Karyn Hede,et al.  Project data sphere to make cancer clinical trial data publicly available. , 2013, Journal of the National Cancer Institute.

[3]  Iain Hrynaszkiewicz,et al.  Sharing of clinical trial data among trialists: a cross sectional survey , 2012, BMJ : British Medical Journal.

[4]  Peter C Gøtzsche,et al.  Strengthening and opening up health research by sharing our raw data. , 2012, Circulation. Cardiovascular quality and outcomes.

[5]  D. Altman,et al.  Sharing Individual Participant Data from Clinical Trials: An Opinion Survey Regarding the Establishment of a Central Repository , 2014, PloS one.

[6]  P. Sandercock,et al.  The International Stroke Trial database , 2011, Trials.

[7]  Frank Rockhold,et al.  Access to patient-level data from GlaxoSmithKline clinical trials. , 2013, The New England journal of medicine.

[8]  R. Little,et al.  The prevention and treatment of missing data in clinical trials. , 2012, The New England journal of medicine.

[9]  Mike Clarke,et al.  Good practice principles for sharing individual participant data from publicly funded clinical trials , 2015, Trials.

[10]  T. Lemmens,et al.  Access to Information and the Right to Health: The Human Rights Case for Clinical Trials Transparency , 2011, American Journal of Law & Medicine.

[11]  Ying Qin,et al.  NIDDK data repository: a central collection of clinical trial data , 2006, BMC Medical Informatics Decis. Mak..

[12]  S. Pocock,et al.  INDANA: a meta-analysis on individual patient data in hypertension. Protocol and preliminary results. , 1995, Therapie.

[13]  Harlan M. Krumholz,et al.  Ushering in a new era of open science through data sharing: the wall must come down. , 2013, JAMA.

[14]  M. Parmar,et al.  Sharing data from clinical trials: the rationale for a controlled access approach , 2015, Trials.

[15]  Michael W. Weiner,et al.  Worldwide Alzheimer’s Disease Neuroimaging Initiative , 2012, Alzheimer's & Dementia.

[16]  Peter C Gøtzsche,et al.  Why we need easy access to all data from all clinical trials and how to accomplish it , 2011, Trials.

[17]  Fiona Godlee,et al.  The new BMJ policy on sharing data from drug and device trials , 2012, BMJ : British Medical Journal.

[18]  D. Perera,et al.  Patient-level data: a paradigm shift in clinical trial transparency? , 2013 .

[19]  Tom Jefferson,et al.  The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience , 2012, PLoS medicine.

[20]  A. Vickers Whose data set is it anyway? Sharing raw data from randomized trials , 2006, Trials.

[21]  Cary P Gross,et al.  The importance of clinical trial data sharing: toward more open science. , 2012, Circulation. Cardiovascular quality and outcomes.

[22]  D. Rennie,et al.  SPIRIT 2013 statement: defining standard protocol items for clinical trials. , 2013, Annals of internal medicine.